Nagababu, E., Ramasamy, S., Abernethy, D
An order confirmation acknowledges receipt but does not necessarily constitute acceptance
doi: 10.1016/j.biopha.2017.10.109 Summary Keywords proliferative vitreoretinopathy, EMT, mechanism, cytokine, therapy, drug delivery system Citation Chen Z, Liu J, Quan L, Wu L and Xu Q (2026) From fibrotic mechanisms to clinical translation: the drug therapy revolution and delivery system breakthrough in proliferative vitreoretinopathy
Definitely recommend this treatment to anyone looking to brighten their skin
Typical conversions from animal studies use body-surface-area scaling: Rat dose: 10 g/kg human equivalent ( 0.162) 1.6 g/kg For a 70 kg adult: ~112 g per day Self-experiment protocols often cite 100200 g once or twice daily via subcutaneous injection
The Australian biotech company Metabolic Pharmaceuticals (later Calzada) was founded to bring AOD-9604 to market